Open AccessVasopressin Receptor Antagonist, Tolvaptan, for Treating Hyponatremia in Patients with Heart Failure
Author(s) -
Kyungjin Kim
Publication year - 2021
Publication title -
cardiovascular prevention and pharmacotherapy
Language(s) - English
Resource type - Journals
ISSN - 2671-700X
DOI - 10.36011/cpp.2021.3.e3
Subject(s) - tolvaptan , hyponatremia , antagonist , vasopressin receptor , vasopressin antagonists , heart failure , medicine , vasopressin , pharmacology , receptor antagonist , receptor